- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07941570
The Impact of Using a Non-motorised Physical Assistance Device on the Prevention of Musculoskeletal Disorders Amongst Care-givers (TM2S)
This experimental study uses a Single-Case Experimental Design (SCED) with multiple baselines across participants to evaluate the impact of a non motorized assistive device (DAP) on muscle effort in care givers during their professional activities. Each participant completes a 12-day protocol consisting of three phases (A1 - B - A2), with the initial baseline (A1, no device) randomized between 2 and 6 days, followed by a 6-day intervention phase (B, wearing the non-motorized DAP), and a final withdrawal phase (A2, no device) adjusted to complete the 12-day period. Muscle effort is continuously quantified as a percentage of maximum voluntary contraction using mechanomyographic sensors (MOTEN Technologies) placed on the lumbar and biceps muscles, as well as the quadriceps at the Fondation Saint-Hélier site.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Bastien Fraudet
- Telefoonnummer: +33299295043
- E-mail: bastien.fraudet@fondationsainthelier.com
Studie Locaties
-
-
-
Landivisiau, Frankrijk
- Fondation Ildys - EHPAD Saint Vincent
-
Contact:
- Manon Le Goff
- Telefoonnummer: +33298028308
- E-mail: manon.legoff@ildys.org
-
Hoofdonderzoeker:
- Sylvia Courtes
-
Ploemeur, Frankrijk, 56270
- Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
-
Contact:
- Marie Caroline Fortuné
- Telefoonnummer: +33297826023
- E-mail: marie-caroline.fortune@vyv3.fr
-
Hoofdonderzoeker:
- Cécile Diot
-
Rennes, Frankrijk
- Fondation Saint Helier
-
Contact:
- Estelle Cézé
- Telefoonnummer: +33299295043
- E-mail: estelle.ceze@fondationsainthelier.com
-
Hoofdonderzoeker:
- Estelle Cézé
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Aged 18 years and older.
- Height between 160 cm and 200 cm.
- Professional care-giver working in SMR (Medical and Rehabilitation Care) or medico-social departments of partner healthcare facilities.
- Willing to wear the non-motorized DAP under the conditions defined by the protocol.
- Affiliated with or beneficiary of a national social security scheme.
- Having provided free and informed written consent.
Exclusion Criteria:
- Self-reported back, leg, or knee pathology that raises doubts regarding the safe use of the non-motorized DAP without prior medical clearance.
- Pregnant, parturient, or breastfeeding women.
- Persons deprived of liberty by a judicial or administrative decision (including legal guardianship, trusteeship, or court protection).
- Persons receiving psychiatric care or admitted to a healthcare or social establishment for reasons other than research.
- Persons in emergency situations unable to express prior informed consent.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Non-motorized DAP Intervention
Single group following a 12-day A1-B-A2 SCED protocol. Participants undergo a randomized baseline of 2-6 days without the device (A1), a 6-day intervention phase wearing the non-motorized DAP during work activities (B), and an adjusted withdrawal phase without the device (A2). |
Participants wear a non-motorized device for posture assistance (DAP) during their regular professional activities as nurse's aides for 6 consecutive days (Phase B of the 12-day A1-B-A2 SCED protocol). Muscle effort is continuously monitored using mechanomyographic sensors (MOTEN Technologies).
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Percentage of Maximum Voluntary Contraction (% MVC) of target muscle groups
Tijdsspanne: Daily during work hours over the 12-day study protocol
|
Muscle effort is continuously quantified via mechanomyography (MMG) using MOTEN Technologies sensors. The primary outcome is the muscle effort level expressed as a percentage of the individual's maximum voluntary contraction (% MVC) for each monitored muscle group (lumbar and biceps muscles across all sites; quadriceps muscles at the Fondation Saint-Hélier site). Measures are compared across the baseline (A1), intervention (B), and withdrawal (A2) phases. |
Daily during work hours over the 12-day study protocol
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in postural strain measured by mechanomyography (MMG)
Tijdsspanne: Daily during work hours over the 12-day study protocol
|
Postural strain during daily professional activities is evaluated using mechanomyographic (MMG) sensors (MOTEN Technologies) placed on target muscle groups. Measures are compared across the baseline (A1), intervention (B), and withdrawal (A2) phases. |
Daily during work hours over the 12-day study protocol
|
|
Change in perceived effort score using a Numerical Rating Scale (NRS)
Tijdsspanne: Twice daily (after each half-day work shift) over the 12-day study protocol
|
Perceived exertion during work tasks is assessed using a 0 to 10 Numerical Rating Scale (NRS/EVN), where 0 represents very low effort and 10 represents very high effort. |
Twice daily (after each half-day work shift) over the 12-day study protocol
|
|
Change in perceived fatigue score using a Numerical Rating Scale (NRS)
Tijdsspanne: Twice daily (before and after each full work day) over the 12-day study protocol
|
Subjective physical fatigue is assessed using a 0 to 10 Numerical Rating Scale (NRS/EVN), where 0 represents very low fatigue and 10 represents very high fatigue. |
Twice daily (before and after each full work day) over the 12-day study protocol
|
|
User satisfaction score with the non-motorized DAP (ESAT questionnaire)
Tijdsspanne: At the end of Phase B (Day 6 of wearing the device)
|
User satisfaction with the assistive device will be assessed using the 8-item Device subscale of the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0 / ESAT). Items are rated on a 5-point Likert scale from 1 to 5, yielding a total sum score ranging from 8 to 40, where higher scores indicate greater satisfaction |
At the end of Phase B (Day 6 of wearing the device)
|
|
Acceptability score based on the UTAUT model
Tijdsspanne: Baseline (prior to Phase A1/B) and Post-Intervention (At the end of day 6 of phase B)
|
Technology acceptance will be assessed across the constructs of the Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire. Each item is rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). Each item also belongs one of several subscales. Mean scores are calculated separately for each subscale, ranging from 1 to 7, where higher scores indicate greater technology acceptance. |
Baseline (prior to Phase A1/B) and Post-Intervention (At the end of day 6 of phase B)
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2026-A01360-51
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .